ENTECAVIR and HEPATIC FAILURE

Overview

HEPATIC FAILURE is the #15 most commonly reported adverse reaction for ENTECAVIR, manufactured by E.R. Squibb & Sons, L.L.C.. There are 219 FDA adverse event reports linking ENTECAVIR to HEPATIC FAILURE. This represents approximately 1.4% of all 15,216 adverse event reports for this drug.

Patients taking ENTECAVIR who experience hepatic failure should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

HEPATIC FAILURE is a less commonly reported adverse event for ENTECAVIR, but still significant enough to appear in the safety profile.

Other Side Effects of ENTECAVIR

In addition to hepatic failure, the following adverse reactions have been reported for ENTECAVIR:

• DEATH — 539 reports
• OFF LABEL USE — 501 reports
• DRUG INEFFECTIVE — 432 reports
• DRUG RESISTANCE — 401 reports
• DIARRHOEA — 364 reports
• FATIGUE — 353 reports
• PYREXIA — 349 reports
• HEPATITIS B — 327 reports
• NAUSEA — 313 reports
• PLATELET COUNT DECREASED — 289 reports

Other Drugs Associated with HEPATIC FAILURE

The following drugs have also been linked to hepatic failure in FDA adverse event reports:

Does ENTECAVIR cause HEPATIC FAILURE?

HEPATIC FAILURE has been reported as an adverse event in 219 FDA reports for ENTECAVIR. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is HEPATIC FAILURE with ENTECAVIR?

HEPATIC FAILURE accounts for approximately 1.4% of all adverse event reports for ENTECAVIR, making it a notable side effect.

What should I do if I experience HEPATIC FAILURE while taking ENTECAVIR?

If you experience hepatic failure while taking ENTECAVIR, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages